Searched for
CENTRE FOR DERMATOLOGIC RESEARCH
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsFor the next few weeks, what needs to be watched is market breadth. And also look at which sectors are leading the rally. Why? Because, at ...
- Market will be volatile, look for an alternative solution: 5 large-caps from different sectors with upside potential of up to 30%A fall in crude oil prices can trigger a relief rally, which in fact it did in early trade on Thursday. But there is another reality as wel...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- ET Women Conclave 2026 spotlights leadership, reinvention, and powerful conversationsThe ET Women Conclave 2026 celebrated inspiring leaders, entrepreneurs, and changemakers with dialogues on authenticity, wellness, and impa...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%We are living in times when the morning may see conciliatory exchanges between the US and Iran, leading to a cooling in crude oil prices. B...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
- Manage short-term risk and volatility for long-term opportunity: 7 stocks from different sectors with upside potential of up to 32%There will be many ifs and buts – and a high volatility quotient – when a market is in its initial phase of correction, especially a correc...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOver the next few trading sessions, the direction of indices like the Nifty and Sensex will be determined by news on ceasefire violations a...
- Time to be contrarian, but with one condition: 5 mid-cap stocks from different sectors with an upside potential up to 32%Here’s what the street will see in the next couple of days: Discussions on whether the market has bottomed; or if an escalation in the war ...
- Pharma sector grows 7.7 per cent in May; FDC ban weighsUnder the non-NLEM category, growth in May for domestic players and MNCs almost doubled to 9 per cent and 7.1 pc as against April's 4.6 pc ...
- Book on modern cosmetic dermatology by L'orealL'oreal has collaborated with Indian dermatologists for a book that aims to shed light on modern cosmetic dermatology & define preventive m...
- Indian scientist awarded with honorary Professorship"This is only the second time in the history of this renowned University that an honorary Professorship has been awarded to a British scien...
- ET Awards 2012-13: With strategy & execution its forte, Sun Pharma is the Company of the YearIt is India’s most valuable pharma company — its market cap has risen nearly five-fold to over Rs 1 lakh crore over the past four fiscals.
- VLCC buys 80% in Singapore-based cosmetics maker GVIG for Rs 180 croreVLCC plans to acquire the remaining 20% stake in GVig, held in the form of sweat equity by some individuals, by next year, Luthra said.
- Elder Pharma to launch 32-35 new products over next 30-monthsThe R&D centre has recently been modernised and expanded and now consists of about 100 scientists.
Load More
